ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
5.64
+0.43 (8.25%)
At close: Dec 5, 2025, 4:00 PM EST
5.75
+0.11 (1.95%)
After-hours: Dec 5, 2025, 6:13 PM EST
ImmuCell Employees
As of December 31, 2024, ImmuCell had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees decreased by 4 or -5.06% compared to the previous year.
Employees
75
Change (1Y)
-4
Growth (1Y)
-5.06%
Revenue / Employee
$370,257
Profits / Employee
$30,982
Market Cap
51.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ICCC News
- 22 days ago - ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025 - GlobeNewsWire
- 4 weeks ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 - GlobeNewsWire
- 4 weeks ago - ImmuCell Announces Onboarding of New CEO and Related Management Changes - GlobeNewsWire
- 2 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 - GlobeNewsWire
- 2 months ago - ImmuCell Announces Selection of its Next President and CEO - GlobeNewsWire
- 4 months ago - ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025 - GlobeNewsWire